ServicenavigationHauptnavigationTrailKarteikarten


Research unit
EU RFP
Project number
04.0009
Project title
GA2LEN: Global allergy and asthma European network

Texts for this project

 GermanFrenchItalianEnglish
Key words
-
-
-
Anzeigen
Alternative project number
-
-
-
Anzeigen
Research programs
-
-
-
Anzeigen
Short description
-
-
-
Anzeigen
Further information
-
-
-
Anzeigen
Abstract
-
-
-
Anzeigen
References in databases
-
-
-
Anzeigen

Inserted texts


CategoryText
Key words
(English)
Asthma; network of excellence
Alternative project number
(English)
EU project number: 506378
Research programs
(English)
EU-programme: 6. Frame Research Programme - 1.5 Urspr. Progr. Food quality and safety
Short description
(English)
See abstract
Further information
(English)
Full name of research-institution/enterprise:
Schweizerisches Institut für Allergie- und Asthmaforschung
Immunologie
Abstract
(English)
Allergic diseases and asthma pose an important and increasing problem for Europe. European research groups already make a major contribution to studies of the causes and management of these conditions. Initiatives from the European Commission have led to increasing collaboration within Europe, but there is still a lack of permanent structures, and there are relatively poor links between disciplines. A network of excellence (NoE) will be the optimal answer to these problems.
GA2LEN (Global Allergy and Asthma European Network) is a NoE of 25 leading European teams, the European Academy of Allergology and Clinical Immunology (EMCI) and a patient's organisation (EFA). The objective is to establish an internationally competitive network, to enhance the quality and relevance of research, address all aspects of the disease, and eventually to decrease the burden of allergy and asthma throughout Europe.
The network will bring together epidemiological, basic and clinical researchers carefully considering ethical and gender issues. It will investigate allergy and asthma across the life course, including intra-uterine life and foeto-maternal interface; interaction between genetic and environmental factors in early life, translation of allergic sensitisation into disease, and persistence of the disease. This will allow development of novel biomarkers, treatments and preventive strategies.
GA2LEN will create a permanent and durable structure that will maximize the scientific contribution of Europe to this area. The network will accelerate the application of research results to clinical practice, patients' needs and policy development, as well as promoting training and integration between public and private sectors.
References in databases
(English)
Swiss Database: Euro-DB of the
State Secretariat for Education and Research
Hallwylstrasse 4
CH-3003 Berne, Switzerland
Tel. +41 31 322 74 82
Swiss Project-Number: 04.0009